BreStem Therapeutics, Inc. Alternatives & Competitors
12 companies similar to BreStem Therapeutics, Inc. — BreStem is a clinical stage biotech company working to fight deadly lung disease...
Companies similar to BreStem Therapeutics, Inc.
ImmuneWorks
Pioneering safe and effective treatments for autoimmune lung diseases through groundbreaki...
Lineage Cell Therapeutics
A clinical-stage biotechnology company developing novel cell therapies for unmet medical n...
Carlsbad, United States
MICA Biosystems
An innovative and dynamic biotech start-up, unlocking the potential of stem cells and nano...
London, United Kingdom
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
New York, United States
Rival Readout
Competing with BreStem Therapeutics, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Israel
Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respirato...
Basel, Switzerland
BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
Cambridge, United States
TC BioPharm
Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP
United Kingdom
Heartseed Inc.
Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiom...
Japan
Aurion Biotech
We're on a mission to cure blindness with our transformational platform of advanced therap...
Seattle, United States
Metcela Inc.
Unleash the Cell Potential.
Kawasaki, Japan
About BreStem Therapeutics, Inc.
**BreStem Therapeutics, Inc.** is a clinical stage biotech company dedicated to combatting fatal lung diseases through innovative stem cell and exosome therapies. The company is at the forefront of the lung regeneration revolution with diverse product platforms that encompass cell therapy, bioengineering, and smart nan...
Biotech, Stem Cell Therapy, Exosome Therapy, Lung Disease, Pulmonary Fibrosis, Clinical Stage, Respiratory Research, FDA Approval, Regenerative Medicine, Cell Therapy, Bioengineering, Nanotechnology, Patient-Specific Therapy, IND Development, Clinical-Stage Biotech
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around BreStem Therapeutics, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at BreStem Therapeutics, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
